NASDAQ:ATNX - Nasdaq - US04685N2027 - Common Stock - Currency: USD
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.07% to 33,325.35 while the NASDAQ rose 0.62% to 12,360.60. The S&P 500, also rose, gaining, 0.27% to 4,135.07.
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
SoFi Technologies (SOFI) stock is on the move Monday after the finance company's stock was hit with a downgrade Wedbush.
為更好地推進事務發展,公司自願申請第 11 章破產程序 公司擁有足夠的資源支援 Athenex Pharma Solutions 的營運,並在此進程期間,完成 APD 客戶訂單 紐約布法羅, May 15, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc.,...
Greenbrook TMS (GBNH) stock is on the move Monday as the therapy center prepares to release its latest earnings report later today.
Athenex (ATNX) stock is falling on Monday after the company announced an agreement with lenders to pursue an expedited sales process.
BUFFALO, N.Y., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery,...
We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!
Media upstart Vice Media LLC and home security company Monitronics International Inc. were among at least seven firms filing for US Chapter 11 bankruptcy protection in the past 24 hours as companies feel the crunch from a year of interest hikes.
Athenex (ATNX) lost ~52% pre-market Monday after announcing that the biotech and some of its subsidiaries filed for Chapter 11 bankruptcy in Texas. Read more here.
To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings Company Has Sufficient Resources to Support Athenex Pharma Solutions Operations and...
/PRNewswire/ -- Quantum Leap Healthcare Collaborative (Quantum Leap) and Athenex, Inc. (Nasdaq: ATNX) will present the findings of the I-SPY 2 TRIAL evaluation...
探索一系列戰略備選方案 2022 年第四季度來自持續經營的產品銷售收入同比增長 +27%,2022 年全年增長 +33% Athenex 於 2022年第四季度應佔淨虧損為 3,420 萬美元,或每股經攤薄股份 4.28 美元,而上年同期為 1.044 億美元,或每股經攤薄股份 19.08 美元 ...
Exploring a range of strategic alternatives Revenues from product sales from continued operations increased +27% Y/Y in 4Q 2022 and +33% for full year...
It's time to start the day with an overview of the biggest pre-market stock movers worth keeping an eye on Thursday morning!
紐約州布法羅市, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ:ATNX),一家致力於癌症和相關疾病治療新療法的發現、開發和商業化的全球生物製藥公司今天宣佈,將於 2023 年 2 月 15 日東部時間上午 12:01...
Athenex (ATNX) on Tuesday said it will effect a 1-for-20 reverse stock split of its issued common stock.
MHRA 僅以化學成分、生產和控制 (CMC) 問題為由拒絕了口服紫杉醇治療轉移性乳腺癌的申請Athenex 計劃要求一個獨立小組對 MHRA 的決定進行審查 MHRA 的申請補充了來自 iSPY 2 研究的安全性數據,未表現出重大臨床療效或安全性問題 紐約州布法羅, Jan. 04, 2023 ...